Tower Research Capital »

Silverback Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4k 231 10.22
2023-09-30 $135k 36k 3.78
2023-06-30 $64k 9.5k 6.70
2023-03-31 $64k 9.7k 6.63
2022-12-31 $71k 8.2k 8.64
2022-09-30 $33k 6.6k 5.05
2022-06-30 $45k 11k 4.26
2022-03-31 $70k 20k 3.52
2021-12-31 $19k 2.8k 6.80
2021-09-30 $53k 4.6k 11.67
2021-06-30 $34k 1.1k 31.02
2021-03-31 $29k 657 44.14